Haemonetics Corp (NYSE:HAE)

86.45
Delayed Data
As of 3:59pm ET
 -1.68 / -1.91%
Today’s Change
58.23
Today|||52-Week Range
91.39
+9.92%
Year-to-Date

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Haemonetics Corp have a median target of 108.00, with a high estimate of 115.00 and a low estimate of 90.00. The median estimate represents a +24.93% increase from the last price of 86.45.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Buy stock in Haemonetics Corp. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.73
Sales
$292.7M
Reporting Date
Aug 08

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -5.43%
 
 
 
 
 
 
Growthannually 18.32%
 
 
 
 
 
 

Sales

Growthquarterly -3.83%
 
 
 
 
 
 
Growthannually 6.37%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.